Improved expression of kinases in Baculovirus-infected insect cells upon addition of specific kinase inhibitors to the culture helpful for structural studies

Protein Expression and Purification

Volumn 56, Issue 2, 2007, Pages 167-176

  Strauss, André ^a   Fendrich, Gabriele ^a   Horisberger, Michel André ^a   Liebetanz, Janis ^a   Meyhack, Bernd ^a   Schlaeppi, Jean Marc ^a   Schmitz, Rita ^a  

^a NOVARTIS PHARMA AG   (Switzerland)

Author keywords

Abl kinase; Baculovirus; Crystallization; Expression; KDR; Kinase inhibitor; PKC

Indexed keywords

ABELSON KINASE; PROTEIN KINASE; PROTEIN KINASE INHIBITOR; RECOMBINANT PROTEIN;

ANIMAL; ARMYWORM; ARTICLE; BACULOVIRUS; BIOLOGICAL MODEL; CELL CULTURE; CELL LINE; CHEMISTRY; CYTOLOGY; GENETICS; METABOLISM; VIROLOGY;

ANIMALS; BACULOVIRIDAE; CELL LINE; CELLS, CULTURED; MODELS, BIOLOGICAL; PROTEIN KINASE INHIBITORS; PROTEIN KINASES; PROTO-ONCOGENE PROTEINS C-ABL; RECOMBINANT PROTEINS; SPODOPTERA;

HEXAPODA;

EID: 35448950408     PISSN: 10465928     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.pep.2007.06.008     Document Type: Article

References (30)

1. Buolamwini J.K. Novel anticancer drug discovery. Curr. Opin. Chem. Biol. 3 (1999) 500-509
2. Schindler T., Bornmann W., Pellicena P., Miller W.T., Clarkson B., and Kuriyan J. Structural mechanism for STI-571 inhibition of abelson tyrosine kinase. Science 289 (2000) 1938-1942
3. McTigue M.A., Wickersham J.A., Pinko C., Showalter R.E., Parast C.V., Tempczyk-Russell A., Gehring M.R., Mroczkowski B., Kan C.C., Villafranca J.E., and Appelt K. Crystal structure of the kinase domain of human vascular endothelial growth factor receptor 2: a key enzyme in angiogenesis. Structure 7 (1999) 319-330
4. Biondi R.M., Komander D., Thomas C.C., Lizcano J.M., Deak M., Alessi D.R., and van Aalten D.M.F. High resolution crystal structure of the human PDK1 catalytic domain defines the regulatory phosphopeptide docking site. EMBO J. 21 (2002) 4219-4228
5. Griffith J., Black J., Faerman C., Swenson L., Wynn M., Lu F., Lippke J., and Saxena K. The structural basis for autoinhibition of FLT3 by the juxtamembrane domain. Mol. Cell 13 (2004) 169-178
6. Rosenblatt J., De Bondt H., Jancarik J., Morgan D.O., and Kim S.H. Purification and crystallization of human cyclin-dependent kinase 2. J. Mol. Biol. 230 (1993) 1317-1319
7. Mauro M.J., and Druker B.J. STI571: targeting BCR-ABL as therapy for CML. Oncologist 6 (2001) 230-232
8. Manley P.W., Cowan-Jacob S.W., Buchdunger E., Fabbro D., Fendrich G., Furet P., Meyer T., and Zimmermann J. Imatinib: a selective tyrosine kinase inhibitor. Eur. J. Cancer 38 Suppl 5 (2002) S19-S27
9. Strauss A., Bitsch F., Cutting B., Fendrich G., Graff P., Liebetanz J., Zurini M., and Jahnke W. Amino-acid-type selective isotope labeling of proteins expressed in Baculovirus-infected insect cells useful for NMR-studies. J. Biomol. NMR 26 (2003) 367-372
10. Bold G., Altmann K.H., Frei J., Lang M., Manley P.W., Traxler P., Wietfeld B., Brüggen J., Buchdunger E., Cozens R., Ferrari S., Furet P., Hofmann F., Martiny- Baron G., Mestan J., Rösel J., Sills M., Stover D., Acemoglu F., Boss E., Emmenegger R., Lässer L., Masso E., Roth R., Schlachter C., Vetterli W., Wyss D., and Wood J.M. New anilinophtalazines as potent and orally well absorbed inhibitors of the VEGF receptor tyrosine kinase useful as antagonists of tumor-driven angiogenesis. J. Med. Chem. 43 (2000) 2310-2323
11. Newton A.C. Protein kinase C: structural and spatial regulation by phosphorylation, cofactors, and macromolecular interactions. Chem. Rev. 101 (2001) 2353-2364
12. Arendt C.W., Albrecht B., Soos T.J., and Littman D.R. Protein kinase C-θ: signaling from the center of the T-cell synapse. Curr. Opin. Immunol. 14 (2002) 323-330
13. Manley P.W., Bold G., Fendrich G., Furet P., Mestan J., Meyer T., Meyhack B., Stark W., Strauss A., and Wood J. Advances in the structural biology, design and clinical development of VEGF-R kinase inhibitors for the treatment of angiogenesis. Cell. Mol. Biol. Lett. 8 (2003) 532-533
14. Manley P.W., Bold G., Bruggen J., Fendrich G., Furet P., Mestan J., Schnell C., Stolz B., Meyer T., Meyhack B., Stark W., Strauss A., and Wood J. Advances in the structural biology, design and clinical development of VEGF-R kinase inhibitors for the treatment of angiogenesis. Biochem. Biophys. Acta 1697 (2004) 17-27
15. G. Rummel, W. Stark, A. Strauss, J. Wagner, Three-dimensional structure of the catalytic domain of Protein Kinase C theta, methods and use thereof, Patent WO 2004/076654 A1 (2003).
16. Strauss A., Bitsch F., Fendrich G., Graff P., Knecht R., Meyhack B., and Jahnke W. Efficient uniform isotope labeling of Abl kinase expressed in Baculovirus-infected insect cells. J. Biomol. NMR 31 (2005) 343-349
17. Bold G., Frei J., Furet P., Manley P.W., Brüggen J., Cozens R., Ferrari S., Hofmann F., Martiny-Baron G., Mestan J., Meyer T., and Wood J.M. CGP 79787D (PTK787/ZK222584), CGP 84738, NVP-AAC789, NVP-AAD777 and related 1-anilino-(4-pyridylmethyl)phthalazines as inhibitors of VEGF- and BFGF-induced angiogenesis. Drugs of the Future 27 (2002) 43-55
18. Hennequin L.F., Thomas A.P., Johnstone C., Stokes E.S.E., Plé P.A., Lohmann J.-J.M., Ogilvie D.J., Dukes M., Wedge S.R., Curwen J.O., Kendrew J., and Lambert-van der Brempt C. Design and structure-activity relationship of a new class of potent VEGF receptor tyrosine kinase inhibitors. J. Med. Chem. 42 (1999) 5369-5389
19. Bit R.A., Davis P.D., Elliott L.H., Harris W., Hill C.H., Keech E., Kumar H., Lawton G., Maw A., Nixon J.S., Vesey D.R., Wadsworth J., and Wilkinson S.E. Inhibitors of protein kinase C. 3. Potent and highly selective bisindolylmaleimides by conformational restriction. J. Med. Chem. 36 (1993) 21-29
20. Wilkinson S.E., Parker P.J., and Nixon J.S. Isoenzyme specificity of bisindolylmaleimides, selective inhibitors of protein kinase C. Biochem. J. 294 (1993) 335-337
21. Davies P.D., Hill C.H., Lawton G., Nixon J.S., Wilkinson S.E., Hurst S.A., Keech E., and Turner S.E. Inhibitors of protein kinase C. 1. 2,3-Bisarylmaleimides. J. Med. Chem. 35 (1992) 177-184
22. Baier G., Telford D., Giampa L., Coggeshall K.M., Baier-Bitterlich G., Isakov N., and Altman A. Molecular cloning and characterization of PKC theta, a novel member of the protein kinase C (PKC) gene family expressed predominantly in hematopoietic cells. J. Biol. Chem. 268 (1993) 4997-5004
23. O'Reilly D.R., Miller L.K., and Luckow V.A. Baculovirus Expression Vectors (1994), Oxford University Press, New York, NY
24. Pyle L.E., Barton P., Fujiwara Y., Mitchell A., and Fidge N. Secretion of biologically active human proapolipoprotein A-1 in a baculovirus-insect cell system: protection from degradation by protease inhibitors. J. Lipid Res. 36 (1995) 2355-2361
25. Martenson P.M., and Justesen J. Specific inhibitors prevent proteolytic degradation of recombinant proteins expressed in High Five™ cells. BioTechniques 30 (2001) 782-792
26. Ramos L., Kopec L.A., Sweitzer S.M., Fornwald J.A., Zhao H., Mcallister P., McNulty D.E., Trill J.J., and Kane J.F. Rapid expression of recombinant proteins in modified CHO cells using the baculovirus system. Cytotechnology 38 (2002) 37-41
27. Spenger A., Ernst W., Condreay J.P., Kost T.A., and Grabherr R. Influence of promoter choice and trichostatin A treatment on expression of baculovirus delivered genes in mammalian cells. Protein Expr. Purif. 38 (2004) 17-23
28. Hassell A.M., An G., Bledsoe R.K., Bynum J.N., Carter III H.L., Deng S.J., Gampe R.T., Grisard T.E., Madauss K.P., Nolte R.T., Rocque W.J., Wang L., Weaver K.L., Williams S.P., Wisely G.B., Xu R., and Shewchuk L.M. Crystallization of protein-ligand complexes. Acta Cryst. D63 (2007) 72-79
29. Vedadi M., Nielsen F.H., Allali-Hassani A., Fedorov O.Y., Finerty Jr. P.J., Wasney G.A., Yeung R., Arrowsmith C., Ball L.J., Berglund H., Hui R., Marsden B.D., Nordlund P., Sundstrom M., Weigelt J., and Edwards A.M. Chemical screening methods to identify ligands that promote protein stability, protein crystallization, and structure determination. Proc. Natl. Acad. Sci. USA 103 43 (2006) 15835-15840
30. Cowan-Jacob S.W. Structural biology of protein tyrosine kinases. Cell. Mol. Life Sci. 63 (2006) 2608-2625